Latest round: Series B. Mike Carruthers serves as the Chief Financial Officer (CFO) of Edgewise Therapeutics.
Mike Carruthers serves as the Chief Financial Officer (CFO) of Edgewise Therapeutics, a biopharmaceutical company focused on muscular dystrophy treatments. He has been active in equity transactions, including selling company stock and receiving RSUs and stock options.
Full founder directory · Investor directory · Company funding database · Fundraising library